MAPT and Alzheimer disease: Although numerous animal models are available for AD research, none can fully replicate the complex neuropathological and behavioral features seen in humans, such as the absence of Aβ plaques in tau-based models or the lack of neurofibrillary tangles (NFTs) in APP-based models.